Dr. Geoffrey Oxnard vice president, global medical lead for Foundation Medicine’s liquid biopsy portfolio, stops by Let’s Talk Medtech to discuss the company’s recent FDA approvals. Oxnard also gives some insight into the liquid biopsy space.
Related Articles